Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, TX
Clinical Trial Details
Research Study Summary
Do You Have Moderate to Severe Rheumatoid Arthritis? Research Study RA0077
An international clinical research study is under way to evaluate and compare the safety and effectiveness of two approved drugs for people living with moderate to severe Rheumatoid Arthritis.
Qualified participants will receive study related medication and care at no cost. In order to participate in this study you must continue to take your Methotrexate as prescribed by your doctor. Other eligibility criteria will apply. You will receive compensation up to $50.00 per study visit.
To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.
Patient Inclusion Criteria:
If you have RA, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:
- Are a man or woman at least 18 years of age
- Have a confirmed diagnosis of Rheumatoid Arthritis, which is considered moderate to severe
Patient Exclusion Criteria:
- Currently not taking Methotrexate.
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.